[Skip to Content]
[Skip to Content Landing]
Views 4,344
Citations 0
Editorial
August 6, 2019

Screening for Pancreatic Cancer—Is There Hope?

Author Affiliations
  • 1The Ludwig Center, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, The Johns Hopkins University, Baltimore, Maryland
  • 2The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University, Baltimore, Maryland
  • 3Departments of Surgery, Medicine, and Radiology and Radiological Science, Johns Hopkins Medicine, The Johns Hopkins University, Baltimore, Maryland
  • 4Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, The Johns Hopkins University, Baltimore, Maryland
  • 5Department of Pathology, Johns Hopkins Medicine, The Johns Hopkins University, Baltimore, Maryland
  • 6Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland
JAMA Intern Med. Published online August 6, 2019. doi:10.1001/jamainternmed.2019.3323

Pancreatic cancer can be a devastating disease. Fewer than 9% of patients with ductal adenocarcinoma of the pancreas are living 5 years after diagnosis. It is estimated that in 2019, about 57 000 people will be diagnosed with pancreatic cancer in the United States and that it may soon overtake colon cancer to become the second-most common cause of cancer-related death.1 Based on recent progress in the treatment of colon cancer, the best hope for reducing the cancer-specific mortality of pancreatic cancer may be early diagnosis and treatment.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×